• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Vacuolar protein sorting-associated protein 13B (VPS13B), Truncated

ACP15296

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP15296 Target NameVPS13B
Target SynonymsCHS1; COH1; Cohen syndrome protein 1; Vacuolar protein sorting 13 homolog B (yeast); Vacuolar protein sorting-associated protein 13B; VP13B_HUMAN; vps13BFormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Protein LengthPartial
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ7Z7G8
Background Information
  • Uniprot Id

    Q7Z7G8

  • Target Species

    Human

  • Target Name

    VPS13B

  • Target Full Name

    Intermembrane lipid transfer protein VPS13B

  • Target Function

    May be involved in protein sorting in post Golgi membrane traffic.

  • Target Involvement

    Cohen syndrome (COH1)

  • Target Protein Families

    VPS13 family

  • Target Tissue Specificity

    Widely expressed. There is apparent differential expression of different transcripts. In fetal brain, lung, liver, and kidney, two transcripts of 2 and 5 kb are identified. These transcripts are also seen in all adult tissues analyzed. A larger transcript

  • Target Synonyms

    CHS1; COH1; Cohen syndrome protein 1; Vacuolar protein sorting 13 homolog B (yeast); Vacuolar protein sorting-associated protein 13B; VP13B_HUMAN; vps13B

Inquire Recombinant Human Vacuolar protein sorting-associated protein 13B (VPS13B), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification